Key Takeaways
- Mercy Medical Center has become the first hospital in the world to use the new MarginProbe 2 technology during breast-conserving surgery.
- The technology provides surgeons with quick and reliable information about the margins of removed tissue, helping to reduce re-excision rates and improve the surgical experience for patients and healthcare providers.
- MarginProbe 2 can confirm if the edges of removed tissue are cancer-free in just a few minutes, allowing surgeons to make informed decisions during surgery.
- The new technology has the potential to reduce the number of patients who need to return for additional surgery, improving patient outcomes and reducing healthcare costs.
Introduction to MarginProbe 2
The use of innovative technology in healthcare has led to significant advancements in various medical fields, including breast cancer surgery. Recently, Mercy Medical Center made history by becoming the first hospital in the world to utilize the new MarginProbe 2 technology during breast-conserving surgery. This cutting-edge technology has the potential to revolutionize the way surgeons perform breast cancer surgery, providing them with quick and reliable information about the margins of removed tissue. By using MarginProbe 2, surgeons can confirm if the edges of removed tissue are cancer-free in just a few minutes, allowing them to make informed decisions during surgery.
The Benefits of MarginProbe 2
The introduction of MarginProbe 2 has been hailed as a game-changer for breast surgery. According to George Makhoul, CEO of Dilon Technologies, the company behind the technology, MarginProbe 2 is helping to reduce re-excision rates and improve the overall surgical experience for both patients and healthcare providers. By providing immediate and reliable margin information, surgeons can avoid the need for additional surgery, which can be a significant benefit for patients. Dr. Vincent Reid, a surgical oncologist at Mercy Medical Center, noted that with MarginProbe 2, he can confirm if all the cancer has been removed within minutes, allowing him to make the best decision for his patient right away.
Reducing Re-Excision Rates
One of the primary benefits of MarginProbe 2 is its ability to reduce re-excision rates. Re-excision is a common problem in breast cancer surgery, where the initial surgery does not remove all the cancerous tissue, requiring additional surgery to remove the remaining cancer. By using MarginProbe 2, surgeons can confirm if the edges of removed tissue are cancer-free, reducing the need for additional surgery. This not only improves patient outcomes but also reduces healthcare costs associated with additional surgery. Mercy Medical Center has been using the original MarginProbe for years and has seen significant improvements in reducing re-excision rates. The new MarginProbe 2 technology improves upon the original, providing even greater accuracy and reliability.
Improving Patient Outcomes
The use of MarginProbe 2 has the potential to significantly improve patient outcomes. By reducing the need for additional surgery, patients can experience less trauma and scarring, leading to better cosmetic outcomes. Additionally, the technology can help reduce the risk of complications associated with additional surgery, such as infection and bleeding. Furthermore, the use of MarginProbe 2 can help reduce the emotional and psychological trauma associated with additional surgery, allowing patients to recover more quickly and return to their normal lives. As the first hospital in the world to use MarginProbe 2, Mercy Medical Center is paving the way for other hospitals to adopt this innovative technology, improving patient outcomes and reducing healthcare costs.
Conclusion
In conclusion, the introduction of MarginProbe 2 is a significant advancement in breast cancer surgery. By providing surgeons with quick and reliable information about the margins of removed tissue, the technology has the potential to reduce re-excision rates and improve patient outcomes. As the first hospital in the world to use MarginProbe 2, Mercy Medical Center is leading the way in the adoption of this innovative technology. With its potential to improve patient outcomes and reduce healthcare costs, MarginProbe 2 is an exciting development in the field of breast cancer surgery, and its use is likely to become more widespread in the coming years.